Quote:
Originally Posted by MeadHallPirate
sounds like a reasonable response matey.
still, for reasons 'o self intrest, i hope this is addressed sometime in 2060, when imma dead. i need merck stock to remain robust till then.
*bows*
|
A good investment choice.
The 11 companies that make up the Fortune 500 drug industry category enjoyed an 18.6 percent return on revenues and a 17.7 percent return on assets. By comparison, the median for all Fortune 500 industries was 4.9 percent and 3.9 percent, respectively. In all, Fortune 500 drug companies saw their return on revenue increase 15 percent from 1999 (see Table 1). That success came at a time when the American economy saw overall profit growth drop from 29 percent in 1999 to 8 percent last year.
One of the many reasons the US has the highest health care costs in the world with mediocre quality of care and a substantial number of Americans without health care. The sheer number of Babyboomers and their health care requirements through the Medicare prescription program putting tremendous financial pressure on Medicare will prompt legislation overturning big pharmos monopolistic pricing structures which penalize Americans.